NSC |
Compound |
Enrichment |
Correlation |
NSC 132277 |
Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) |
0.0119221520283057 |
0.33337995 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0119221520283057 |
0.20912086 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0119221520283057 |
0.30885121 |
NSC 13484 |
Null |
0.0119221520283057 |
0.44919093 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.0119221520283057 |
0.28514872 |
NSC 319947 |
2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- |
0.0119221520283057 |
0.18600327 |
NSC 382032 |
Null |
0.0119221520283057 |
0.18815292 |
NSC 608984 |
Leucinostatine D |
0.0119221520283057 |
0.043281761 |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.0119221520283057 |
0.44050794 |
NSC 636984 |
Null |
0.0119221520283057 |
0.32627154 |